Literature DB >> 26894579

Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.

Barbara Depreter, Katrien M J Devreese.   

Abstract

BACKGROUND: Lupus anticoagulant (LAC) testing includes a screening, mixing and confirmation step. Although recently published guidelines on LAC testing are a useful step towards standardization, a lack of consensus remains whether to express mixing tests in clotting time (CT) or index of circulating anticoagulant (ICA). The influence of anticoagulant therapy, e.g. vitamin K antagonists (VKA) or direct oral anticoagulants (DOAC) on both methods of interpretation remains to be investigated. The objective of this study was to contribute to a simplification and standardization of the LAC three-step interpretation on the level of the mixing test.
METHODS: Samples from 148 consecutive patients with LAC request and prolonged screening step, and 77 samples from patients non-suspicious for LAC treated with VKA (n=37) or DOAC (n=30) were retrospectively evaluated. An activated partial thromboplastin time (aPTT) and dilute Russell's viper venom time (dRVVT) were used for routine LAC testing. The supplemental anticoagulant samples were tested with dRVVT only. We focused on the interpretation differences for mixing tests expressed as CT or ICA and compared the final LAC conclusion within each distinct group of concordant and discordant mixing test results.
RESULTS: Mixing test interpretation by CT resulted in 10 (dRVVT) and 16 (aPTT) more LAC positive patients compared to interpretation with ICA. Isolated prolonged dRVVT screen mix ICA results were exclusively observed in samples from VKA-treated patients without suspicion for LAC.
CONCLUSIONS: We recommend using CT in respect to the 99th percentile cut-off for interpretation of mixing steps in order to reach the highest sensitivity and specificity in LAC detection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26894579     DOI: 10.1515/cclm-2015-0978

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?

Authors:  Pieter M M De Kesel; Katrien M J Devreese
Journal:  Res Pract Thromb Haemost       Date:  2019-12-10

2.  Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time in a patient with Hashimoto thyroiditis-associated thyroid cancer: A case report.

Authors:  Yuhong Zhong; Biyong Yan; Zhongqi Yu; Lin Wang
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

3.  Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study.

Authors:  Franz Ratzinger; Tanja Panic; Helmuth Haslacher; Thomas Perkmann; Klaus G Schmetterer; Sabine Belik; Georg Maenner; Ingrid Pabinger; Peter Quehenberger
Journal:  Biochem Med (Zagreb)       Date:  2017-08-28       Impact factor: 2.313

4.  Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant.

Authors:  Osamu Kumano; Gary W Moore
Journal:  Res Pract Thromb Haemost       Date:  2019-07-30

5.  Lupus anticoagulant test persistence over time and its associations with future thrombotic events.

Authors:  Meaghan E Colling; Cihan Ay; Daniel Kraemmer; Silvia Koder; Peter Quehenberger; Ingrid Pabinger; Florian Posch; Johanna Gebhart
Journal:  Blood Adv       Date:  2022-05-24

6.  Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples.

Authors:  Gary W Moore; James C Maloney; Naomi de Jager; Clare L Dunsmore; Dervilla K Gorman; Richard F Polgrean; Maria L Bertolaccini
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20

7.  Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant.

Authors:  Osamu Kumano; Gary W Moore
Journal:  Res Pract Thromb Haemost       Date:  2017-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.